It is well known that loss of neurofibromin leads to the hyperactivation of RAS and downstream effectors, thus making vascular cells more sensitive to different growth factors and thereby contributing to the heterogeneity of disease manifestations observed in NF1 patients [52]. The gene discussed is NF1; the disease is neurofibromatosis type 1.